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Abstract
Background: Uncomplicated acute appendicitis can be managed with non-operative (antibiotic) treatment, but laparoscopic appen-
dicectomy remains the first-line management in the UK. During the COVID-19 pandemic the practice altered, with more patients of-
fered antibiotics as treatment. A large-scale observational study was designed comparing operative and non-operative management
of appendicitis. The aim of this study was to evaluate 90-day follow-up.
Methods: A prospective, cohort study at 97 sites in the UK and Republic of Ireland included adult patients with a clinical or radiologi-
cal diagnosis of appendicitis that either had surgery or non-operative management. Propensity score matching was conducted using
age, sex, BMI, frailty, co-morbidity, Adult Appendicitis Score and C-reactive protein. Outcomes were 90-day treatment failure in the
non-operative group, and in the matched groups 30-day complications, length of hospital stay (LOS) and total healthcare costs asso-
ciated with each treatment.
Results: A total of 3420 patients were recorded: 1402 (41 per cent) had initial antibiotic management and 2018 (59 per cent) had ap-
pendicectomy. At 90-day follow-up, antibiotics were successful in 80 per cent (1116) of cases. After propensity score matching (2444
patients), fewer overall complications (OR 0.36 (95 per cent c.i. 0.26 to 0.50)) and a shorter median LOS (2.5 versus 3 days, P< 0.001)
were noted in the antibiotic management group. Accounting for interval appendicectomy rates, the mean total cost was e1034 lower
per patient managed without surgery.
Conclusion: This study found that antibiotics is an alternative first-line treatment for adult acute appendicitis and can lead to cost
reductions.
Introduction
Antibiotics as the first-line treatment for adult acute appendicitis
is an accepted, but often overlooked, strategy1. Recent trial evi-
dence has reported that antibiotics can be successful and avoid
surgery in the majority of uncomplicated acute appendicitis,
both in the short and longer term2–8. In addition, international
guidelines state antibiotics are safe and an effective alternative
to surgery in patients with uncomplicated acute appendicitis
where imaging has not shown the presence of a faecolith9.
Despite this, implementation of antibiotics as first-line treatment
has not occurred and laparoscopic appendicectomy remains the
first-line treatment for acute appendicitis in Europe and the
USA9,10.
The first wave of the SARS-COV-2 (COVID-19) pandemic raised
significant concerns around the choice of surgical intervention:
potentially increased morbidity and mortality in those infected
with COVID-19 having an operation; and viral transmission via
aerosolization during laparoscopy. These concerns led to profes-
sional surgical societies recommending non-operative manage-
ment with antibiotics over surgery as first-line management of
acute appendicitis11,12. Anticipating a significant shift in practice,
the authors designed and implemented a pragmatic, observational,
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unselected cohort study of management of uncomplicated acute
appendicitis.
The collaborative’s previous publication on the first 500 adult
patients confirmed a significant shift in practice towards non-
operative management of acute appendicitis and a higher num-
ber of CT scans (71 per cent) performed to aid diagnosis during
the pandemic13. This publication also reported on the successful
short-term safety and efficacy of non-operative management as
first-line treatment up to 30 days from diagnosis13. The authors
now report on the complete study cohort with the primary aim of
documenting the 90-day success rate of non-operative manage-
ment. Secondary aims were analysis of factors influencing out-
come and reporting the relative costs of non-operative versus
operative management at 90 days.
Methods
Ethical approval was not required as the study collected routine,
anonymized data and no clinical care was influenced.
Study design
A prospective, multicentre study in the UK and the Republic of
Ireland on patients aged at least 18 years diagnosed either clini-
cally and/or radiologically with acute appendicitis in a secondary
care setting was carried out. The patients were managed initially
either with antibiotic (non-operative) or operative management.
Data was collected from patients presenting from the date of the
UK Government COVID-19 lockdown on 23 March 2020 (28 March
2020 in the Republic of Ireland) until 23 June 2020. Study registra-
tion was overseen by the local principal investigator at each site
as either a clinical audit or service evaluation. This observational
study was reported according to STROBE guidelines for observa-
tional studies, where appropriate14.
Site recruitment and data collection
Any hospital in the UK or Republic of Ireland providing emer-
gency care for patients diagnosed with acute appendicitis could
participate. The protocol was published15, and trainee-led re-
search collaboratives and social media (@covidharem) aided re-
cruitment of sites. Publicity for the project was supported by The
Association of Surgeons of Great Britain and Ireland (ASGBI) and
the Royal College of Surgeons of England.
Local teams screened patients presenting with abdominal
pain to identify patients eligible for inclusion. Once screened, col-
laborators entered anonymized data of patients meeting inclu-
sion criteria to Research Electronic Data Capture (REDCap , www.
project-redcap.org)16. The database was developed, maintained
and hosted by the Major Trauma Team at Nottingham University
Hospitals, UK (@EastMidsMTC).
Group allocation
Decision for first-line/initial treatment of acute appendicitis was
at the discretion of the clinical team independent of the study
team. No guidance was offered by the study team although na-
tional professional bodies had issued guidance on the investiga-
tion and management of appendicitis during the pandemic11,12. If
the decision was surgery within the first 2 days of presentation,
this patient was entered into the study in the operative group; if
the decision was for antibiotics, this patient entered the non-
operative management group.
Outcome measures
Admission variables were recorded for all patients including de-
mographic data, frailty, co-morbidities, patient observations, du-
ration of symptoms and blood inflammatory markers. Sites were
asked to calculate an Adult Appendicitis Score (AAS) for each pa-
tient using an online calculator (www.appendicitisscore.com).
Patients in both cohorts were followed up for 90 days from pre-
sentation for total length of hospital stay (LOS), death, rate of
hospital reattendance, operations, interventional radiology (IR)
drain placement, and admission to critical care (level 2 (high de-
pendency unit) or 3 (intensive care unit)), 30-day complication
rate and total costs. Operative details were recorded including
surgical approach, duration of operation, procedure, surgical
findings and histology.
Patient demographics and outcomes were analysed by inten-
tion to treat by initial operative or non-operative management.
Failure of non-operative management was recorded as manage-
ment changing from antibiotics to surgery at least 2 days after
initial assessment. Patients requiring IR drainage on initial pre-
sentation were excluded from the main analysis as initial man-
agement was neither non-operative nor operative.
Data validation
Random number generation was used to select 15 per cent of
patients entered into the database for data validation. Sites were
asked to nominate an independent team member to collect data
for a predetermined 25 per cent of data points for these randomly
selected patients. These data were analysed centrally against the
database and generated an overall data validation percentage of
98.1 per cent. Sites with data validation below 95 per cent were
excluded from the analysis.
Statistical analysis
Due to missing data, all outcome proportions were reported as
the number of events/total patients with data. Descriptive data
were reported as median (i.q.r.) or rates as appropriate.
Differences in demographics between the non-operative and op-
erative groups were analysed using Mann–Whitney U and
Fisher’s exact test as appropriate. Standardized differences (SD)
are presented to show the differences between groups in baseline
characteristics, with values of greater than 0.1 regarded as dem-
onstrating imbalance between the groups17.
In order to reduce the effects of selection bias in this non-ran-
domized cohort, propensity score matching was performed using
a probit model for the following variables: age, sex, frailty status,
Adult Appendicitis Score10, presence of obesity, diabetes, chronic
obstructive pulmonary disease (COPD), previous myocardial in-
farction and C-reactive protein (CRP). Matching was performed
one to one to the nearest neighbour (without replacement) within
a calliper of 0.118. Violin plots for propensity score distributions
can be found in Supplementary material online, Figs S1 and S2.
Following matching, conditional logistic regression was per-
formed and differences between matched groups are presented
as odds ratios and 95 per cent confidence intervals. Length of
stay was analysed using negative binomial regression due to
overdispersion. This outcome is presented as an incident rate ra-
tio and 95 per cent confidence intervals. All statistical analysis
was performed using StataVR version 16.1 (StataCorp, www.stata.
com). The user-written commands psmatch2 and stddiff were
used.
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Cost analysis
The cost analysis undertook a time horizon of 90 days, and was
undertaken from the hospital perspective. The costs included
were those pertaining to the index hospital admission, and any
subsequent readmissions. Resource use categories were defined
a priori and include those where differences between groups are
likely to drive incremental costs. These are the duration of hospi-
tal admission including days in critical care and ward, duration
and choice of surgical approach (open or laparoscopic), the use of
antibiotics, the use of imaging and any subsequent readmissions.
Total costs at 90 days were calculated by combining resource-use
data at the patient level with unit costs at 2018–2019 prices in
pounds sterling, reported in Euros at a conversion rate of 1:1.16.
The results were subjected to extensive sensitivity analyses, in-
cluding the potential for unmeasured confounding and the ap-
proach taken in the unit costs analysis. A detailed breakdown of
the costings used are available in Supplementary material online,
Tables S2 and S3.
Results
A total of 3420 patients were included in the analysis (Fig. 1): 48
per cent (1643 patients) were female; median age 36 (i.q.r. 26–52)
years. Overall COVID-19 positivity was low at 1 per cent (32
patients).
Acute appendicitis was treated first line with non-operative
management in 41 per cent (1402 patients) and operative man-
agement in 59 per cent (2018 patients). Laparoscopic appendicec-
tomy was performed in 65 per cent (1298 patients), laparoscopic
converted to open in 3 per cent (61 patients) and open
appendicectomy in 32 per cent (644 patients). At 90 days’ follow-
up, 80 per cent (1116 of 1402) of the non-operative group had
avoided operative intervention. Baseline characteristics by group
are shown in Table 1.
Patients with laboratory-confirmed COVID-19 infection on ad-
mission were more likely to undergo non-operative management:
11 patients in the operative group and 21 in the non-operative
management group (P< 0.001). Blood inflammatory markers
were significantly different between the two groups; the median
CRP on admission of those in the operative group was 49 mg/L
(i.q.r. 14–127) and in the non-operative group was 33 mg/L (i.q.r.
8–98) (P< 0.001), and white cell count was 13.9 109/L (i.q.r. 11.1–
16.8) and 12.5 109/L (i.q.r. 9.8–15.6) respectively (P< 0.001).
Patients who had non-operative management were more
likely to have an ultrasound scan performed than those in the op-
erative group (23 versus 15 per cent, P< 0.001). CT was performed
in 70 per cent of patients in both groups, with a faecolith present
in 30 per cent (713 patients) of all patients. Of those found to
have a faecolith, 73 per cent (523 patients) were managed opera-
tively and 27 per cent (190 patients) were initially managed non-
operatively (P< 0.001).
Outcomes after unsuccessful non-operative
management
Non-operative management was unsuccessful leading to surgery
in 20 per cent (286) of patients; 60 per cent (170 patients) had a
laparoscopic approach, 35 per cent (98 patients) open and 5 per
cent (13 patients) had a laparoscopic converted to open proce-
dure (Fig. 1). The median time interval to change of management
from non-operative to operative management was 2 (i.q.r. 2–7)
Total patients
n = 3475






































Fig. 1 Study flow chart
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Age (years)* 36 (26–52) 36.5 (27–52) 35 (26–52) 0.002 0.345
Female 1643 of 3419 (48) 919 of 2018 (46) 724 of 1401 (52) 0.13 <0.001
BMI (kg/m2)
<20.0 199 of 3297 (6) 102 of 1937 (5) 97 of 1360 (7) 0.11 0.032
20.1–25.0 1256 of 3297 (38) 739 of 1937 (38) 517 of 1360 (38)
25.1–30.0 1144 of 3297 (35) 665 of 1937 (34) 479 of 1360 (35)
30.1–35.0 475 of 3297 (14) 304 of 1937 (16) 171 of 1360 (13)
>35.1 223 of 3297 (7) 127 of 1937 (7) 96 of 1360 (7)
Rockwood clinical frailty score
Not frail (1–4) 3341 of 3419 (98) 1987 of 2018 (98) 1354 of 1401 (97) 0.12 0.001
Frail (5–9) 78 of 3419 (2) 31 of 2018 (2) 47 of 1401 (3)
Co-morbidity
COPD 76 of 3420 (2) 43 of 2018 (2) 33 of 1402 (2) 0.02 0.724
Myocardial infarction 96 of 3420 (3) 47 of 2018 (2) 49 of 1402 (4) 0.07 0.046
Diabetes 134 of 3420 (4) 76 of 2018 (4) 58 of 1402 (4) 0.02 0.592
Active cancer 34 of 3420 (1) 17 of 2018 (1) 17 of 1402 (1) 0.04 0.297
Immunosuppressed 57 of 3419 (2) 31 of 2018 (2) 26 of 1401 (2) 0.02 0.499
Smoking status
Current 499 of 3411 (15) 298 of 2014 (15) 201 of 1397 (14) 0.05 0.371
Previous 283 of 3411 (8) 156 of 2014 (8) 127 of 1397 (9)
Never 2629 of 3411 (77) 1560 of 2014 (77) 1069 of 1397 (77)
Adult Appendicitis Score group
Low risk 628 of 3420 (18) 266 of 2018 (13) 362 of 1402 (26) 0.42 <0.001
Intermediate risk 1765 of 3420 (52) 1016 of 2018 (50) 749 of 1402 (53)
High risk 1207 of 3420 (30) 736 of 2018 (36) 291 of 1402 (21)
Duration of symptoms
<24 hours 1074 of 3414 (31) 653 of 2014 (32) 421 of 1400 (30) 0.15 0.001
25–48 hours 1155 of 3414 (34) 690 of 2014 (34) 465 of 1400 (33)
49–72 hours 451 of 3414 (13) 273 of 2014 (14) 178 of 1400 (13)
73–96 hours 298 of 3414 (9) 182 of 2014 (9) 116 of 1400 (8)
>97 hours 436 of 3414 (13) 216 of 2014 (11) 220 of 1400 (16)
Temperature on admission
<37.4 2410 of 3408 (71) 1360 of 2011 (68) 1050 of 1397 (75) 0.19 <0.001
37.5–37.9 598 of 3408 (18) 371 of 2011 (18) 227 of 1397 (16)
38–38.4 274 of 3408 (8) 189 of 2011 (9) 85 of 1397 (6)
>38.5 126 of 3408 (4) 91 of 2011 (5) 35 of 1397 (3)
Heart rate on admission
>90 beats per minute 1330 of 3406 (39) 825 of 2008 (41) 505 of 1398 (36) 0.1 0.004
Imaging
Ultrasound 610 of 3420 (18) 293 of 2018 (15) 317 of 1402 (23) 0.21 <0.001
Magnetic resonance imaging 32 of 3420 (1) 17 of 2018 (1) 15 of 1402 (1) 0.02 0.589
Computed tomography 2402 of 3420 (70) 1418 of 2018 (70) 984 of 1402 (70) 0.002 0.970
Ultrasound and CT 150 of 3420 (4) 68 of 2018 (3) 82 of 1402 (6) 0.12 0.001
Appendix histology Unsuccessful NOM (n¼ 286)
Acute appendicitis 1855 of 1974 (94) 232 of 277 (84) 0.31 <0.001
Chronic appendicitis 10 of 1974 (0.5) 7 of 277 (3) 0.17 0.003
Malignancy 29 of 1974 (1) 4 of 277 (1) 0.002 1.000
Neuroendocrine tumour 7 of 1974 (0.4) 3 of 277 (1) 0.09 0.115
Normal 55 of 1974 (3) 18 of 277 (6) 0.17 0.003
Other 18 of 1974 (1) 9 of 277 (3) 0.16 0.004
Operative approach
Open 644 of 1998 (32) 98 of 281 (35) 0.06 0.378
Laparoscopic 1293 of 1998 (65) 170 of 281 (60) 0.09 0.184
Laparoscopic converted to open 61 of 1998 (3) 13 of 281 (5) 0.06 0.205
Operation performed
Appendicectomy 1972 of 1999 (99) 266 of 281 (95) 0.21 <0.001
Right hemicolectomy 22 of 1999 (1) 10 of 281 (4) 0.16 0.004
Laparoscopy/washout 10 of 1999 (0.5) 4 of 281 (2) 0.10 0.083
Other 2 of 1999 (0.1) 1 of 281 (0.4) 0.05 0.326
Grade of surgeon
Consultant 414 of 2012 (21) 83 of 284 (29) 0.23 0.003
Registrar 1280 of 2012 (64) 153 of 284 (54)
Core trainee 239 of 2012 (12) 32 of 284 (11)
Other 79 of 2012 (4) 16 of 284 (6)
Values in parentheses are percentages unless indicated otherwise; bold text denotes values of statistical significance;*values are median (i.q.r.).†P values of
significance are highlighted in bold.
NOM, non-operative management
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days. The majority of decisions to change management strategy
occurred in the first week (76 per cent), with 80 per cent occurring
in the first 2 weeks. Operative procedures performed were appen-
dicectomy (95 per cent, 266 patients), right hemicolectomy with
anastomosis (4 per cent, 10 patients), washout and drain (1 per
cent, 4 patients) and other (0.4 per cent, 1 patient) with missing
data for 5 patients (2 per cent) (Table 1). Operative duration was
less than 90 minutes in 79 per cent (225 of 285 patients) of cases
where antibiotics were unsuccessful compared with 77 per cent
in the initial surgery group (1545 of 1997 patients) (P¼ 0.601).
More than a quarter of patients that had unsuccessful non-
operative management did not have a CT (28 per cent, 80 of 284
patients). Of those that did, 91 per cent (186 of 204 patients) had
CT features of appendicitis, meaning only 65 per cent of patients
had confirmed appendicitis. Faecolithiasis was associated with
unsuccessful non-operative management, present in 25 per cent
(51 of 204) of patients with unsuccessful non-operative manage-
ment and 18 per cent (139 of 777) of patients with successful
non-operative management (P¼ 0.087). The presence of a faeco-
lith was associated with a higher rate of perforated appendicitis
and gangrenous appendicitis at operation when compared with
patients who did not have a faecolith: 47 and 21 per cent versus
20 and 7 per cent respectively.
Histological examination of the appendix in patients with un-
successful non-operative management showed acute appendici-
tis in 84 per cent (232 of 277 patients), chronic or previous
appendicitis in 3 per cent (7 of 277), malignancy in 1 per cent (4 of
277), neuroendocrine tumour in 1 per cent (4 of 277), normal in 6
per cent (18 patients) and ‘other’ in 3 per cent (9 patients). The
LOS in patients who had unsuccessful non-operative manage-
ment was a median of 4 (i.q.r. 3–6) days. The outcomes of these
patients are shown in Table 2.
Matched outcomes
A comparison of propensity score-matched patients (1222
matched patients in each group by co-variables listed in
Supplementary material online, Table S1) is shown in Table 3.
Median LOS was shorter in the non-operative management group
(2.5 (i.q.r. 1–4) versus 3 (i.q.r. 2–4) days, P< 0.001). There was no
difference between operative and non-operative groups for risk of
serious complications, including myocardial infarctions, venous
thromboembolism, unplanned critical care admission or death.
Hospital-acquired pneumonia (odds ratio 0.16; 95 per cent c.i.
0.05 to 0.45), wound infection (odds ratio 0.22; 95 per cent c.i. 0.12
to 0.42) and intra-abdominal collections (odds ratio 0.48; 95 per
cent c.i. 0.32 to 0.74) were significantly lower in the non-operative
group as opposed to matched operative management patients,
giving a lower overall risk of complications (odds ratio 0.36; 95
per cent c.i. 0.26 to 0.50). There was an increase in unplanned
reattendances and readmissions in the non-operative group
(odds ratio 1.39; 95 per cent c.i. 1.11 to 1.75).
Negative appendicectomy
Overall, the negative appendicectomy rate was 3 per cent (68 of
2274 patients): the appendix was histologically normal in 3 per
cent (50 of 1994 patients) of those having initial operative man-
agement and 6 per cent (18 of 280 patients) of those who had un-
successful non-operative management (P¼ 0.001). The majority
of normal appendicectomies were performed in women: 72 per
cent (36 of 50) in the operative group and 78 per cent (14 of 18) in
the unsuccessful non-operative group.
Cost analysis at 90 days
At 90 days, the operative management group incurred higher
mean costs per patient than the non-operative group. The incre-
mental cost per patient in the non-operative management group
was e1034 (95 per cent c.i. –e1201 to e865), that is a saving of
that amount. The results were robust to alternative assumptions
made in the sensitivity analyses, including the potential for
unmeasured confounding or the approach taken in the unit cost
calculation (Supplementary material online, Tables S2–S5 and Fig.
S3). Costs were generally similar between the two groups across
the resource-use categories. The main driver of differences in
costs was the cost of appendicectomy in the primary admission,
which was not offset by the costs accrued by patients in the non-
operative management group who had appendicectomy in subse-
quent readmissions.
Table 2 Outcomes in unsuccessful non-operative management patients
Outcome Frequency (n¼286)
Length of hospital stay (days)* 4 (3–6)
Intra-abdominal collection†
Managed with antibiotics alone 12 of 284 (4)
Managed with interventional radiology drain 1 of 286 (0.4)
Postoperative ileus‡ 20 of 284 (7)
Wound infection§
Managed with antibiotics alone 10 of 284 (4)
Requiring incision and drainage 4 of 284 (1)
HAP
Managed with oral antibiotics 1 of 284 (0.4)
Managed with intravenous antibiotics 2 of 283 (0.7)
MI 0 of 284 (0)
DVT/PE 0 of 284 (0)
COVID-19 6 of 284 (2)
Death (30 days) 1 of 284 (0.4)
Unplanned level 2 of 3 care 6 of 284 (2)
Unplanned reattendances within 90 days 63 of 274 (23)
Any complications (collection, COVID-19, wound infections, HAP,
MI, DVT/PE and death)
28 of 283 (10)
Values in parentheses are percentages unless indicated otherwise; *values are median (i.q.r.). †Collection refers to an infected fluid collection or intra-abdominal
abscess requiring treatment. ‡Ileus was defined as a partial or complete non-mechanical blockade of the small intestine. §Wound infection includes both
superficial and deep incisional surgical-site infection, defined according to Centres for Disease Control and Prevention criteria as superficial as ‘involving only skin
and subcutaneous tissues’ and deep as ‘involving deep structures such as fascia or muscle’. HAP, hospital-acquired pneumonia; MI, myocardial infarction; DVT/PE,
deep vein thrombosis/pulmonary embolism.
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Discussion
This large, multicentre cohort study shows that treatment of ap-
pendicitis with antibiotics can be successful in 80 per cent of
patients by 90 days after presentation. Supported by high levels of
CT scanning, non-operative management has fewer complications,
results in less time in hospital and even if an interval appendicec-
tomy is performed in some patients, the total costs per patient are
lower compared with those for operative management.
The non-operative success rate of 80 per cent confirms results
from similar trials that found antibiotics can avoid emergency sur-
gery for the majority of patients with uncomplicated appendicitis
(71 per cent and 84 per cent)19,20. The non-operative group was un-
selected, included nearly double the number of patients of the
CODA trial, five times that of the APPAC trial and represents the
largest ever series of adult appendicitis patients managed non-oper-
atively19,20.
There were fewer complications and a shorter LOS in the non-
operative group, a finding paralleled in other studies and main-
tained in those which report long-term follow-up21,22. There was
little evidence that failure of non-operative management led to
more complicated operations or worse outcomes; rates of lapa-
roscopically completed appendicectomy and operative durations
were not significantly different from those for patients who were
treated operatively from admission. Of the one in five who failed
non-operative management, the LOS was 1 day longer than that
for those who had initial operative management.
Even accounting for those who required interval appendicec-
tomy, the average cost per patient was lower in the non-
operative group with a mean reduction of –e1034 (95 per cent c.i.
–e1201 to e865). These findings are consistent with other cost-
analysis studies, although previous cost-analysis comparison
was against open appendicectomy23,24. In practice, the cost of
laparoscopic appendicectomy varies between surgeons25, depen-
dent primarily on the use of energy or stapling devices for appen-
dix base closure. To account for this the unit cost of laparoscopic
surgery was varied over values compatible with alternative
appendiceal stump closure techniques in sensitivity analysis.
Sensitivity analysis also accounted for laparoscopic appendicec-
tomy being performed at usual rates (95 per cent)10 rather than
the reduced rate seen during the pandemic.
Current guidelines recommend that a faecolith on imaging
should be treated with surgery9. As a result, clinical trials have ex-
cluded patients with a faecolith2,19. Despite this 27 per cent of
patients with an identified faecolith were managed non-operatively.
However, a higher percentage of patients with unsuccessful non-
operative management had a faecolith present and those with a
faecolith who had unsuccessful non-operative management had
more severe appendicitis on subsequent operation, with higher
rates of gangrene and perforation than those without19. This will be
explored further in the planned 1-year follow-up.
Potential missed appendiceal malignancy is a clinical concern
of non-operative management. This study found four cases of
malignancy and three neuroendocrine tumours in the initial
non-operative management group, and an overall rate of malig-
nancy of 1.3 per cent, consistent with the population reported in-
cidence of 0.5–1.7 per cent26. Known risk factors for appendiceal
malignancy are age, appendiceal dilatation on CT and compli-
cated appendicitis26,27. Again, longer follow-up will give a clearer
picture of this risk.
In addition to providing assessment of potential markers of
malignancy, CT scanning is sensitive for diagnosing appendici-
tis28 and the higher use in this study (70 per cent versus 18 per
cent of patients presenting with right iliac fossa pain in 2019)10, is
likely to have directly influenced the low overall negative appen-
dicectomy rate (3 versus 20 per cent previously reported by the
RIFT Study Group)10. However, CT involves ionizing radiation and
consideration should be given towards contrast-enhanced low-
dose CT scanning in younger adults29,30.
Following the landmark Montgomery UK Supreme Court rul-
ing in 2015, the concept of informed consent has been re-evalu-
ated31. Surgeons are required to present all treatment options
including the benefits, risks of harm and likelihood of success for
each option32. As part of these legal requirements, non-operative







Odds ratio or incident
rate ratio†
Unsuccessful non-operative management N/A 249 of 1222 (20)
Length of hospital stay (days)* 3 (2–4) 2.5 (1–4) 0.89 (0.83, 0.95)
Intra-abdominal collection 68 of 1212 (6) 34 of 1216 (3) 0.48 (0.32, 0.74)
Managed with antibiotics 68 of 1212 (6) 31 of 1217 (3) 0.43 (0.28, 0.67)
Managed with interventional radiology drain 6 of 1222 (0.5) 5 of 1221 (0.4) 0.83 (0.25, 2.73)
Postoperative ileus 72 of 1212 (6) 22 of 1217 (2) 0.28 (0.17, 0.46)
Wound infection 52 of 1212 (4) 12 of 1216 (1) 0.22 (0.12, 0.42)
Managed with antibiotics 46 of 1212 (4) 11 of 1216 (1) 0.24 (0.12, 0.46)
Requiring incision and drainage 15 of 1212 (1) 5 of 1216 (0.4) 0.33 (0.12, 0.92)
HAP 25 of 1212 (2) 4 of 1217 (0.3) 0.16 (0.05, 0.45)
Managed with oral antibiotics 5 of 1212 (0.4) 1 of 1217 (0.1) 0.20 (0.02, 1.71)
Managed with intravenous antibiotics 22 of 1212 (2) 3 of 1217 (0.3) 0.14 (0.04, 0.46)
MI 1 of 1212 (0.1) 2 of 1216 (0.2) 2.00 (0.18, 22.1)
DVT/PE 5 of 1212 (0.4) 1 of 1217 (0.1) 0.20 (0.02, 1.71)
COVID-19 9 of 1212 (0.7) 10 of 1217 (0.8) 1.11 (0.45, 2.73)
Death (30 days) 4 of 1212 (0.3) 2 of 1217 (0.2) 0.50 (0.09, 2.73)
Unplanned level 2/3 care 13 of 1212 (1) 8 of 1217 (0.7) 0.62 (0.26, 1.48)
Unplanned re-attendances within 90 days 163 of 1171 (14) 216 of 1170 (18) 1.39 (1.11, 1.75)
Any complications (collection, COVID-19, wound infections,
HAP, MI, DVT/PE and death)
141 of 1212 (12) 55 of 1215 (5) 0.36 (0.26, 0.50)
Values in parentheses are percentages unless indicated otherwise; bold text denotes values of statistical significance. *values are median (i.q.r.). †Values in
parentheses are 95 per cent confidence intervals. HAP, hospital-acquired pneumonia; MI, myocardial infarction; DVT/PE, deep vein thrombosis/pulmonary
embolism.
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as well as operative management should form part of every sur-
geon’s discussion of treatment options for acute appendicitis.
Previously clinicians had cited concerns over the external validity
of RCT evidence as a reason not to offer non-operative manage-
ment. This study demonstrates the first time non-operative man-
agement has been implemented by UK surgeons and used on a
wide scale in the surgical population.
As an observational study, there was no standardized antibi-
otic protocol and the decision to proceed with surgery was at the
clinician’s discretion. There is inherent bias when implementing
any novel management, and it is challenging to capture changes
that result from a different consultant taking over the patient’s
care, therefore there is the possibility of residual confounding. A
large proportion of patients in the antibiotic group were diag-
nosed clinically, meaning that a presumed diagnosis of appendi-
citis was given to some patients. This could be a confounder for
how many patients had truly unsuccessful non-operative man-
agement, particularly those with normal appendix histology. CT
was not used universally as in previous RCTs. This is a strength
as resource constraints in the National Health Service would
probably prevent universal CT scanning if non-operative man-
agement were adopted in the future. However, this may have
contributed to the 6 per cent negative appendicectomy rate in the
group managed non-operatively.
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